Oscar Health, Inc. (NYSE:OSCR) Receives $21.56 Average PT from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has earned an average rating of “Hold” from the nine research firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $21.56.

Several analysts have commented on the stock. UBS Group initiated coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price for the company. Finally, Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th.

Insider Buying and Selling

In other Oscar Health news, Vice Chairman Joshua Kushner acquired 276,040 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were acquired at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Steven Wolin sold 19,580 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company’s stock, valued at $1,854,971.84. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors have recently modified their holdings of the business. Harbor Capital Advisors Inc. raised its position in shares of Oscar Health by 39.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 128,167 shares of the company’s stock worth $1,723,000 after purchasing an additional 36,577 shares during the last quarter. ORG Wealth Partners LLC acquired a new position in shares of Oscar Health during the fourth quarter valued at approximately $100,000. Nordea Investment Management AB purchased a new position in shares of Oscar Health in the fourth quarter valued at approximately $1,056,000. JPMorgan Chase & Co. boosted its stake in shares of Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after acquiring an additional 938,742 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in shares of Oscar Health during the third quarter worth approximately $600,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Price Performance

Shares of OSCR stock opened at $14.96 on Friday. The stock has a 50 day moving average price of $14.96 and a 200 day moving average price of $16.85. The firm has a market capitalization of $3.70 billion, a P/E ratio of -249.29 and a beta of 1.70. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health has a 52-week low of $10.45 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the company earned ($0.29) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. As a group, sell-side analysts predict that Oscar Health will post -0.01 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.